Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations

BACKGROUND: Androgen deprivation therapy (ADT) is foundational in the management of advanced prostate cancer (PCa) and has benefitted from a recent explosion in scientific advances. These include approval of new therapies that suppress testosterone (T) levels or inactivate its function, improvements...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Prostate Cancer Prostatic Dis
Autors principals: Crawford, E. David, Heidenreich, Axel, Lawrentschuk, Nathan, Tombal, Bertrand, Pompeo, Antonio C. L., Mendoza-Valdes, Arturo, Miller, Kurt, Debruyne, Frans M. J., Klotz, Laurence
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2018
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6370592/
https://ncbi.nlm.nih.gov/pubmed/30131604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41391-018-0079-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars